HIGHLIGHTS
- What: The authors propose that TDR1 is a novel tardigrade specific responsible for conferring resistance to 1 of 35 __NEWPAGE__IR. Expression of TDR1 proteins diminishes the number of phosphoH2AX foci in human U2OS cells treated with Bleomycin Next, the authors aimed to investigate whether the expression of TDR1 could impact the number of phospho-H2AX foci detected upon treatment of human U2OS cells with the radiomimetic drug Bleomycin.
- Who: Chromosomes and colleagues from the Département AVIV, CNRS, INSERM, Département AVIV, CNRS Department of Life Sciences, University of Modena and Reggio Emilia, Italy NBFC . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.